- Home
- TSSI vs CSTL Comparison
TSSI vs CSTL Comparison
Compare TSSI & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSSI
- CSTL
- Stock Information
- Founded
- TSSI 2004
- CSTL 2007
- Country
- TSSI United States
- CSTL United States
- Employees
- TSSI N/A
- CSTL N/A
- Industry
- TSSI Professional Services
- CSTL Medical Specialities
- Sector
- TSSI Consumer Discretionary
- CSTL Health Care
- Exchange
- TSSI Nasdaq
- CSTL Nasdaq
- Market Cap
- TSSI 572.8M
- CSTL 661.7M
- IPO Year
- TSSI N/A
- CSTL 2019
- Fundamental
- Price
- TSSI $8.61
- CSTL $33.40
- Analyst Decision
- TSSI
- CSTL Strong Buy
- Analyst Count
- TSSI 0
- CSTL 6
- Target Price
- TSSI N/A
- CSTL $38.67
- AVG Volume (30 Days)
- TSSI 2.1M
- CSTL 462.2K
- Earning Date
- TSSI 11-13-2025
- CSTL 11-03-2025
- Dividend Yield
- TSSI N/A
- CSTL N/A
- EPS Growth
- TSSI 7.63
- CSTL N/A
- EPS
- TSSI 0.19
- CSTL N/A
- Revenue
- TSSI $234,837,000.00
- CSTL $343,530,000.00
- Revenue This Year
- TSSI N/A
- CSTL N/A
- Revenue Next Year
- TSSI N/A
- CSTL N/A
- P/E Ratio
- TSSI $45.84
- CSTL N/A
- Revenue Growth
- TSSI 91.66
- CSTL 10.15
- 52 Week Low
- TSSI $5.63
- CSTL $14.59
- 52 Week High
- TSSI $31.94
- CSTL $35.49
- Technical
- Relative Strength Index (RSI)
- TSSI 22.92
- CSTL 72.48
- Support Level
- TSSI $15.51
- CSTL $32.51
- Resistance Level
- TSSI $16.80
- CSTL $35.49
- Average True Range (ATR)
- TSSI 1.41
- CSTL 1.70
- MACD
- TSSI -0.74
- CSTL 0.56
- Stochastic Oscillator
- TSSI 3.24
- CSTL 82.39
About TSSI TSS Inc.
TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.